Illumina, Inc. (ILMN)

NMS – Цена в реальном времени. Валюта: USD

145.70

+3.19 (2.24%)

При закрытии: May 12, 2026, 4:00 PM EDT

147.50

+1.80 (1.23%)

После закрытия: May 12, 2026, 7:59 PM EDT

Обзор
Новости
График
Финансы
Дивиденды
Прогноз
Владельцы
Профиль

Illumina, Inc. (ILMN)

Получите доступ ко всем премиум-функциям лучшего инструмента для анализа акций

Finranks

Компания

Контакты

Мы в соцсетях

Illumina, Inc. (ILMN)

Why Illumina (ILMN) is a Top Momentum Stock for the Long-Term

Here's Why Illumina (ILMN) is a Strong Growth Stock

ILMN Stock Up on Q1 Earnings & Revenue Beat, Margins Expand, '26 View Up

Illumina, Inc. (ILMN) Q1 2026 Earnings Call Transcript

Illumina (ILMN) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates

Unlocking Q1 Potential of Illumina (ILMN): Exploring Wall Street Estimates for Key Metrics

AnaptysBio, Inc. (ANAB) May Report Negative Earnings: Know the Trend Ahead of Q1 Release

Видео

Пресс-релизы

DRAGEN v4.5 supports Illumina's new TruPath Genome and 5-base assays, drives insights across germline, oncology, and multiomic workflows

Illumina and the Center for Data-Driven Discovery in Biomedicine bring genomic data and scalable software to the fight against pediatric cancer and rare disease

Illumina Announces Changes to Board of Directors

Illumina and Labcorp expand collaboration to broaden access to precision oncology testing

Search stocks

Illumina, Inc. (ILMN)

Получите доступ ко всем премиум-функциям лучшего инструмента для анализа акций

Finranks

Компания

Контакты

Мы в соцсетях

Illumina, Inc. (ILMN)

Why Illumina (ILMN) is a Top Momentum Stock for the Long-Term

Here's Why Illumina (ILMN) is a Strong Growth Stock

ILMN Stock Up on Q1 Earnings & Revenue Beat, Margins Expand, '26 View Up

Illumina, Inc. (ILMN) Q1 2026 Earnings Call Transcript

Illumina (ILMN) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates

Unlocking Q1 Potential of Illumina (ILMN): Exploring Wall Street Estimates for Key Metrics

AnaptysBio, Inc. (ANAB) May Report Negative Earnings: Know the Trend Ahead of Q1 Release

Видео

Пресс-релизы

DRAGEN v4.5 supports Illumina's new TruPath Genome and 5-base assays, drives insights across germline, oncology, and multiomic workflows

Illumina and the Center for Data-Driven Discovery in Biomedicine bring genomic data and scalable software to the fight against pediatric cancer and rare disease

Illumina Announces Changes to Board of Directors

Illumina and Labcorp expand collaboration to broaden access to precision oncology testing